Related Experiment Video

Updated: Feb 4, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

[EVALUATION OF CARDIOVASCULAR RISKS WITH THE USE OF MORPHOGENETIC KLOTHO PROTEIN IN PATIENTS WITH CHRONIC RENAL

N A Mukhin, L Yu Milovanova, V V Fomin

    Klinicheskaia Meditsina
    |October 11, 2018
    PubMed

    Insights

    Klotho protein levels decrease early in chronic kidney disease (CKD), indicating cardiovascular risk. Angiotensin receptor blockers may help maintain Klotho levels in CKD patients.

    Area of Science:

    • Nephrology
    • Cardiology
    • Biochemistry

    Background:

    • Chronic kidney disease (CKD) is associated with cardiovascular complications.
    • Klotho protein is implicated in aging and kidney function.
    • Understanding Klotho's role in CKD is crucial for risk assessment.

    Purpose of the Study:

    • To investigate the significance of Klotho protein across different stages of CKD.
    • To evaluate the impact of antihypertensive therapy on serum Klotho levels.

    Main Methods:

    • Study included 130 patients with stage 5 CKD.
    • Measured serum Klotho, PTH, calcium, phosphorus, and blood pressure.
    • Utilized ELISA, echocardiography, and vascular imaging techniques.

    Main Results:

    • Serum Klotho decreased earlier than phosphate and PTH in CKD stages (starting from 3A).
    • Low Klotho (<387 pg/ml) predicted myocardial calcification risk (80% sensitivity, 76% specificity).
    • Angiotensin receptor blockers (ARB) were associated with higher Klotho levels compared to other antihypertensives or uncontrolled BP.

    Conclusions:

    • Klotho protein serves as an early diagnostic marker for cardiovascular risk in CKD.
    • Reduced Klotho levels were less pronounced with ARB use for hypertension.
    • Normal Klotho levels correlate with lower cardiovascular calcification in CKD patients.
    Abstract

    More Related Videos

    Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies10:11

    Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

    Published on: October 22, 2014

    19.7K
    In Silico Clinical Trials for Cardiovascular Disease09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    2.3K

    Related Concept Videos

    Psychoneuroimmunology: Cardiovascular Disease01:27

    Psychoneuroimmunology: Cardiovascular Disease

    Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
    A key area of focus in PNI is the relationship between stress and coronary...
    573
    Chronic Kidney Disease I: Introduction01:25

    Chronic Kidney Disease I: Introduction

    Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
    728
    Chronic Obstructive Pulmonary Disease01:24

    Chronic Obstructive Pulmonary Disease

    COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
    Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
    2.5K
    Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

    Chronic Obstructive Pulmonary Disease-II: Pathophysiology

    Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
    Chronic Inflammation
    4.5K
    Chronic Obstructive Pulmonary Disease-I: Introduction01:20

    Chronic Obstructive Pulmonary Disease-I: Introduction

    Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
    3.7K
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    3.2K